Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
题目
Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
作者
Renuka Suvarna, Sahana Shetty, Joseph M. Pappachan
Scihuhuan